EntryPoint Capital’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-894
Closed -$338K 808
2026
Q1
$338K Hold
894
0.1% 420
2025
Q4
$383K Buy
+894
New +$389K 0.15% 259
2024
Q4
Sell
-520
Closed -$313K 755
2024
Q3
$313K Buy
520
+41
+9% +$23.2K 0.18% 234
2024
Q2
$260K Buy
479
+332
+226% +$190K 0.12% 257
2024
Q1
$94.4K Buy
147
+18
+14% +$10.9K 0.08% 459
2023
Q4
$75.4K Buy
+129
New +$72.2K 0.07% 529

Other funds holding CHE

EntryPoint Capital's CHE Position: Q2 2026 in Review

EntryPoint Capital sold out of Chemed (CHE) in Q2 2026, closing a stake of 894 shares — an estimated $338K sold.

EntryPoint Capital first reported a position in CHE in Q4 2023 and held it in 6 quarters. The position peaked at $383K in Q4 2025. 532 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • EntryPoint Capital reported no remaining Chemed position as of Q2 2026 after selling out during the quarter.
  • EntryPoint Capital sold 894 Chemed shares in Q2 2026, an estimated $338K.
  • EntryPoint Capital first reported a position in Chemed in Q4 2023 and held it in 6 quarters.
  • EntryPoint Capital's Chemed position peaked at $383K in Q4 2025.
  • 532 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on EntryPoint Capital's 13F filing for Q2 2026, filed 13 Aug 2026.